X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (2442) 2442
humans (1542) 1542
rats (1457) 1457
receptor, trka - metabolism (1381) 1381
nerve growth-factor (1343) 1343
index medicus (1210) 1210
neurosciences (1208) 1208
trka (1187) 1187
nerve growth factor (1119) 1119
male (885) 885
mice (827) 827
receptor, trka - genetics (747) 747
ngf (729) 729
receptor, trka (707) 707
pc12 cells (706) 706
female (692) 692
expression (661) 661
biochemistry & molecular biology (631) 631
nerve growth factor - metabolism (603) 603
nervous system (552) 552
receptors, nerve growth factor - metabolism (552) 552
cell biology (504) 504
immunohistochemistry (501) 501
phosphorylation (498) 498
neurons (493) 493
signal transduction (489) 489
cells, cultured (451) 451
rats, sprague-dawley (448) 448
neurons - metabolism (421) 421
nerve growth factor - pharmacology (418) 418
neurotrophins (379) 379
receptors, nerve growth factor - genetics (376) 376
apoptosis (375) 375
p75 (363) 363
nerve growth factors - metabolism (352) 352
nerve growth factors - pharmacology (342) 342
receptors (322) 322
activation (313) 313
messenger-rna (307) 307
receptor protein-tyrosine kinases - metabolism (305) 305
proto-oncogene proteins - metabolism (302) 302
oncology (301) 301
differentiation (291) 291
survival (290) 290
gene expression (283) 283
proteins (279) 279
cells (275) 275
article (274) 274
neurotrophin (273) 273
neurons - cytology (272) 272
neurons - drug effects (270) 270
receptor (270) 270
neurotrophic factor (266) 266
neurotrophin receptors (261) 261
signal-transduction (261) 261
research (257) 257
receptor, nerve growth factor (254) 254
proto-oncogene proteins - genetics (251) 251
brain (250) 250
rna, messenger - metabolism (247) 247
signal transduction - physiology (245) 245
trka protein (240) 240
molecular sequence data (239) 239
sensory neurons (237) 237
signal transduction - drug effects (237) 237
analysis (234) 234
trka receptors (234) 234
receptor protein-tyrosine kinases - genetics (231) 231
rats, wistar (226) 226
blotting, western (224) 224
physiological aspects (218) 218
adult (213) 213
pain (211) 211
transfection (208) 208
receptor, nerve growth factor - metabolism (207) 207
nerve growth factor - genetics (206) 206
tyrosine (202) 202
rat (197) 197
time factors (197) 197
cell line, tumor (196) 196
receptor, trkb - metabolism (196) 196
mutation (195) 195
sympathetic neurons (195) 195
cell line (191) 191
alzheimers-disease (190) 190
cancer (189) 189
middle aged (188) 188
neurite outgrowth (188) 188
receptor, trka - antagonists & inhibitors (179) 179
protein (178) 178
tyrosine kinase (178) 178
kinases (177) 177
amino acid sequence (176) 176
ganglia, spinal - metabolism (175) 175
cell differentiation - drug effects (174) 174
multidisciplinary sciences (174) 174
protein binding (174) 174
system (174) 174
brain-derived neurotrophic factor (173) 173
dose-response relationship, drug (173) 173
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3829) 3829
Chinese (30) 30
Russian (17) 17
Japanese (11) 11
French (4) 4
Italian (3) 3
Spanish (3) 3
German (2) 2
Korean (2) 2
Portuguese (2) 2
Finnish (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Aging Cell, ISSN 1474-9718, 08/2016, Volume 15, Issue 4, pp. 661 - 672
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2014, Volume 9, Issue 3, p. e91940
Glioblastoma multiforme (GBM) is the most aggressive form of brain tumor, yet with no targeted therapy with substantial survival benefit. Recent studies on... 
CELL LUNG-CANCER | GENE FUSIONS | PROTEIN | LANDSCAPE | MULTIDISCIPLINARY SCIENCES | PROSTATE-CANCER | RECEPTOR | IDENTIFICATION | INHIBITOR | FAMILY | Cell Adhesion Molecules - chemistry | NIH 3T3 Cells | Cell Adhesion Molecules - genetics | Oncogene Proteins, Fusion - metabolism | Molecular Sequence Data | Male | Nerve Growth Factors - metabolism | Brain Neoplasms - metabolism | Oncogene Proteins, Fusion - chemistry | Base Sequence | Glioblastoma - metabolism | Brevican - genetics | Amino Acid Sequence | Nerve Growth Factors - chemistry | Brevican - chemistry | Cell Adhesion Molecules - metabolism | Carcinogenesis - pathology | Animals | Receptor, trkA - metabolism | Brevican - metabolism | Mice, Nude | Nerve Growth Factors - genetics | Oncogene Proteins, Fusion - genetics | Receptor, trkA - chemistry | Receptor, trkA - genetics | Mice | Mice, Inbred BALB C | Surveys | RNA sequencing | RNA | Genes | Brain tumors | Genomics | Nerve growth factor | Genomes | Genetic aspects | Glioblastoma multiforme | Neurophysiology | Cancer | Cell proliferation | Brain | Biomedical research | Exons | Brain cancer | Lung cancer | Glioblastoma | Science | Kinases | Proteins | Signal transduction | Animal tissues | TrkA protein | Protein-tyrosine kinase receptors | TrkA receptors | Fusion protein | Protein-tyrosine kinase | Tyrosine | Medical research | Immunoglobulins | Agar | Data processing | Gene expression | Ribonucleic acid--RNA | Survival | Signaling | Gene amplification | Solid tumors | Tumors | Ribonucleic acid
Journal Article
Biochemical Journal, ISSN 0264-6021, 12/2012, Volume 448, Issue 2, pp. 213 - 220
To investigate the range of autoinhibitory mechanisms used by TKDs (tyrosine kinase domains) from the insulin receptor family of RTKs (receptor tyrosine... 
X-ray crystallography | Insulin receptor kinase | Autoinhibition | Receptor tyrosine kinase (RTK) | Receptor tyrosine kinase-like orphan receptor 2 (Ror2) | Tropomyosin receptor kinase A (TrkA) | ALK | ACTIVATION | CRYSTAL-STRUCTURE | TYROSINE KINASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | CATALYTIC DOMAIN | autoinhibition | receptor tyrosine kinase-like orphan receptor 2 (Ror2) | CANCER | ANAPLASTIC LYMPHOMA KINASE | insulin receptor kinase | receptor tyrosine kinase (RTK) | MUTATIONS | INHIBITOR | tropomyosin receptor kinase A (TrkA) | EGF RECEPTOR | Neoplasms - metabolism | Humans | Receptor, trkA - antagonists & inhibitors | Crystallography, X-Ray | Antigens, CD - genetics | Antigens, CD - metabolism | Neoplasms - genetics | Receptor, Insulin - genetics | Protein Structure, Quaternary | Antigens, CD - chemistry | Recombinant Proteins - metabolism | Amino Acid Sequence | Catalytic Domain | Recombinant Proteins - antagonists & inhibitors | Receptor Tyrosine Kinase-like Orphan Receptors - metabolism | Models, Molecular | Recombinant Proteins - chemistry | Recombinant Proteins - genetics | Receptor, Insulin - antagonists & inhibitors | Amino Acid Motifs | Receptor Tyrosine Kinase-like Orphan Receptors - antagonists & inhibitors | Receptor Tyrosine Kinase-like Orphan Receptors - chemistry | Receptor, trkA - metabolism | Receptor, Insulin - chemistry | Receptor, trkA - chemistry | Receptor, trkA - genetics | Receptor Tyrosine Kinase-like Orphan Receptors - genetics | Receptor, Insulin - metabolism | Mutation | Enzyme Activation - genetics | In Vitro Techniques | ALK, anaplastic lymphoma kinase | FGFR, fibroblast growth factor receptor | Trk, tropomyosin receptor kinase | C-lobe, C-terminal lobe | EGFR, epidermal growth factor receptor | TKD, tyrosine kinase domain | DTT, dithiothreitol | NSCLC, non-small-cell lung cancer | TCEP, tris-(2-carboxyethyl)phosphine | COSMIC, Catalogue Of Somatic Mutations In Cancer | Ni-NTA, Ni2+-nitrilotriacetate | N-lobe, N-terminal lobe | RTK, receptor tyrosine kinase | CDK, cyclin-dependent kinase | IGF1R, insulin-like growth factor 1 receptor | MuSK, muscle-specific kinase | IRK, insulin receptor kinase | Ror, receptor tyrosine kinase-like orphan receptor
Journal Article
Laboratory Investigation, ISSN 0023-6837, 11/2017, Volume 97, Issue 11, pp. 1268 - 1270
Neurotrophic tyrosine kinase genes encode for the Trk-family proteins TrkA, TrkB, and TrkC, which have an important role in the development of the nervous... 
MEDICINE, RESEARCH & EXPERIMENTAL | ADVANCED SOLID TUMORS | ENTRECTINIB | ORAL PAN-TRK | RELEVANT MOLECULAR ALTERATIONS | PATHOLOGY | ALK INHIBITOR | ROS1 | EXPRESSION | Lung Neoplasms - drug therapy | Oncogene Proteins, Fusion - metabolism | Membrane Glycoproteins - metabolism | Humans | Lung Neoplasms - metabolism | Receptor, trkA - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Receptor, trkB - genetics | Membrane Glycoproteins - antagonists & inhibitors | Receptor, trkC - genetics | Antineoplastic Agents - adverse effects | Neoplasms, Squamous Cell - drug therapy | Receptor, trkB - antagonists & inhibitors | Lung Neoplasms - genetics | Molecular Targeted Therapy - adverse effects | Receptor, trkC - antagonists & inhibitors | Membrane Glycoproteins - genetics | Animals | Neoplasms, Squamous Cell - genetics | Receptor Protein-Tyrosine Kinases - genetics | Receptor, trkA - metabolism | Oncogene Proteins, Fusion - genetics | Receptor, trkA - genetics | Oncogene Proteins, Fusion - antagonists & inhibitors | Receptor, trkB - metabolism | Receptor, trkC - metabolism | Neoplasms, Squamous Cell - metabolism | Toxicity | Lung cancer | Clinical trials | Fluorescence | Nervous system | Kinases | Proteins | Fluorescence in situ hybridization | TrkA protein | TrkA receptors | Protein-tyrosine kinase | Tyrosine | Medical research | Squamous cell carcinoma | Invasiveness | Feasibility studies | Lung carcinoma | Patients | Brain-derived neurotrophic factor | Inhibitors | TrkB receptors | Solid tumors | Tumors | Cancer | Plastic foam | Index Medicus
Journal Article
Cancer Discovery, ISSN 2159-8274, 04/2017, Volume 7, Issue 4, pp. 400 - 409
Entrectinib, a potent oral inhibitor of the tyrosine kinases TRKA/B/C, ROS1, and ALK, was evaluated in two phase I studies in patients with advanced or... 
REARRANGEMENT | ONCOGENE | ONCOLOGY | ANALOG SECRETORY CARCINOMA | LANDSCAPE | KINASE FUSIONS | SARCOMAS | ETV6-NTRK3 GENE FUSION | CRIZOTINIB | GENOMIC ALTERATIONS | CLINICAL-RESPONSE | Benzamides - pharmacokinetics | Colorectal Neoplasms - genetics | Humans | Middle Aged | Receptor, trkA - antagonists & inhibitors | Male | Receptor, trkB - genetics | Indazoles - administration & dosage | Protein Kinase Inhibitors - adverse effects | Mammary Analogue Secretory Carcinoma - genetics | Dose-Response Relationship, Drug | Benzamides - administration & dosage | Membrane Glycoproteins - antagonists & inhibitors | Receptor, trkC - genetics | Anaplastic Lymphoma Kinase | Melanoma - genetics | Colorectal Neoplasms - drug therapy | Receptor, trkB - antagonists & inhibitors | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Benzamides - adverse effects | Carcinoma, Non-Small-Cell Lung - pathology | Crizotinib | Protein Kinase Inhibitors - pharmacokinetics | Proto-Oncogene Proteins - antagonists & inhibitors | Pyridines - administration & dosage | Carcinoma, Non-Small-Cell Lung - genetics | Receptor, trkC - antagonists & inhibitors | Melanoma - pathology | Mammary Analogue Secretory Carcinoma - drug therapy | Membrane Glycoproteins - genetics | Protein Kinase Inhibitors - administration & dosage | Sequestosome-1 Protein - genetics | Pyrazoles - administration & dosage | Indazoles - pharmacokinetics | Receptor Protein-Tyrosine Kinases - genetics | Oncogene Proteins, Fusion - genetics | Melanoma - drug therapy | Adolescent | Receptor, trkA - genetics | Oncogene Proteins, Fusion - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Indazoles - adverse effects | Colorectal Neoplasms - pathology | Protein-Tyrosine Kinases - antagonists & inhibitors
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 5241 - 9
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 12/2017, Volume 143, Issue 6, pp. 645 - 659
Journal Article
Cancer Discovery, ISSN 2159-8274, 09/2017, Volume 7, Issue 9, pp. 963 - 972
Journal Article
Molecular Oncology, ISSN 1574-7891, 12/2014, Volume 8, Issue 8, pp. 1495 - 1507
Journal Article